California-based bioprinting company Organovo is well-known to those in both the 3D printing and medical research worlds, due to its 3D printed kidney and liver tissues. The company, which previously announced its intention to develop a functional, transplantable 3D printed human liver, presented data just a few months ago that shows its ExVive 3D printed tissue is able to survive and function inside an animal test subject. The world may need that 3D printed liver soon, as deteriorating liver function is an increasingly serious public health concern. Hopefully this could start turning around, as Organovo recently announced that it has received a $1.7 million grant from the National Institutes of Health (NIH) to study non-alcoholic fatty liver disease (NAFLD) with researchers from the UC San Diego School of Medicine. Read more at 3DPrint.com: https://3dprint.com/183710/organovo-nih-grant/